Bellecapital International Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Bellecapital International Ltd.

$484 Million
Q3 2024

A detailed history of Bellecapital International Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bellecapital International Ltd. holds 13,598 shares of REGN stock, worth $9.72 Million. This represents 2.95% of its overall portfolio holdings.

Number of Shares

13,598

Previous 13,372 1.69%

Holding current value

$9.72 Million

Previous $14.1 Million 1.71%

% of portfolio

2.95%

Previous 3.1%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$1024.09 - $1201.76 $231,444 - $271,597	226 Added 1.69%	13,598 $14.3 Million
Q2 2024 Jul 19, 2024	BUY	$883.2 - $1071.19 $169,574 - $205,668	192 Added 1.46%	13,372 $14.1 Million
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $142,625 - $156,949	158 Added 1.21%	13,180 $12.7 Million
Q4 2023 Jan 22, 2024	BUY	$775.18 - $881.7 $389,140 - $442,613	502 Added 4.01%	13,022 $11.4 Million
Q3 2023 Oct 17, 2023	BUY	$692.45 - $844.37 $104,559 - $127,499	151 Added 1.22%	12,520 $10.3 Million
Q2 2023 Jul 07, 2023	SELL	$700.03 - $830.35 $2,800 - $3,321	-4 Reduced 0.03%	12,369 $8.89 Million
Q1 2023 Apr 25, 2023	BUY	$680.49 - $826.97 $140,180 - $170,355	206 Added 1.69%	12,373 $10.2 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $118,589 - $128,753	168 Added 1.4%	12,167 $8.78 Million
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $1.52 Million - $1.92 Million	2,648 Added 28.32%	11,999 $8.27 Million
Q2 2022 Jul 27, 2022	BUY	$548.35 - $738.84 $5.13 Million - $6.91 Million	9,351 New	9,351 $5.53 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.

Account

Bellecapital International Ltd. Regeneron Pharmaceuticals, Inc. Transaction History